This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Bernard Emile Joseph Gout: Innovator in Adrenomedullin Receptor Research
Introduction
Bernard Emile Joseph Gout is a notable inventor based in Rennes, France. He has made significant contributions to the field of medical research, particularly in the area of adrenomedullin receptor polynucleotides. His work has implications for various medical conditions, showcasing the potential of his innovations.
Latest Patents
Gout holds a patent for "Adrenomedullin receptor polynucleotides." This patent includes putative adrenomedullin receptor polypeptides and polynucleotides, along with methods for producing these polypeptides through recombinant techniques. The patent also outlines methods for utilizing these polypeptides and polynucleotides in designing treatment protocols for a range of infections, including bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV-1 or HIV-2. Additionally, it addresses treatments for pain, cancers, diabetes, obesity, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure, and various other conditions.
Career Highlights
Throughout his career, Gout has focused on innovative approaches to medical treatment. His research has led to advancements in understanding the role of adrenomedullin receptors in various diseases. His patent reflects a commitment to improving therapeutic strategies for complex health issues.
Collaborations
Gout has collaborated with notable colleagues, including Philippe Laurent Robert and Michel Louis Souchet. These partnerships have likely contributed to the depth and breadth of his research endeavors.
Conclusion
Bernard Emile Joseph Gout is a distinguished inventor whose work in adrenomedullin receptor research has the potential to impact numerous medical fields. His innovative approaches and collaborations highlight the importance of continued research in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile